Diverse roles of non-diverse molecules: MHC class Ib molecules in host defense and control of autoimmunity

Current Opinion in Immunology

Volumn 23, Issue 1, 2011, Pages 104-110

  Hofstetter, Amelia R ^a   Sullivan, Lucy C ^b   Lukacher, Aron E ^a   Brooks, Andrew G ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD94 ANTIGEN; GLYCOSPHINGOLIPID; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQA1 ANTIGEN; HLA E ANTIGEN; NATURAL KILLER CELL RECEPTOR NKG2A; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR QA 1B; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOTOXICITY; DENDRITIC CELL; HOST RESISTANCE; HUMAN; IMMUNOGENICITY; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADAPTIVE IMMUNITY; ANIMALS; AUTOIMMUNITY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNITY, INNATE; T-LYMPHOCYTES;

EID: 79951682868     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2010.09.009     Document Type: Review

References (70)

1. Rodgers J.R., Cook R.G. MHC class Ib molecules bridge innate and acquired immunity. Nat Rev Immunol 2005, 5:459-471.
2. Hansen T.H., Huang S., Arnold P.L., Fremont D.H. Patterns of nonclassical MHC antigen presentation. Nat Immunol 2007, 8:563-568.
3. Florence W.C., Xia C., Gordy L.E., Chen W., Zhang Y., Scott-Browne J., Kinjo Y., Yu K.O., Keshipeddy S., Pellicci D.G., et al. Adaptability of the semi-invariant natural killer T-cell receptor towards structurally diverse CD1d-restricted ligands. EMBO J 2009, 28:3579-3590.
4. Mallevaey T., Scott-Browne J.P., Matsuda J.L., Young M.H., Pellicci D.G., Patel O., Thakur M., Kjer-Nielsen L., Richardson S.K., Cerundolo V., et al. T cell receptor CDR2 beta and CDR3 beta loops collaborate functionally to shape the iNKT cell repertoire. Immunity 2009, 31:60-71.
5. Middendorp S., Nieuwenhuis E.E. NKT cells in mucosal immunity. Mucosal Immunol 2009, 2:393-402.
6. Mattner J., Debord K.L., Ismail N., Goff R.D., Cantu C., Zhou D., Saint-Mezard P., Wang V., Gao Y., Yin N., et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005, 434:525-529.
7. De Libero G., Moran A.P., Gober H.J., Rossy E., Shamshiev A., Chelnokova O., Mazorra Z., Vendetti S., Sacchi A., Prendergast M.M., et al. Bacterial infections promote T cell recognition of self-glycolipids. Immunity 2005, 22:763-772.
8. Paget C., Mallevaey T., Speak A.O., Torres D., Fontaine J., Sheehan K.C., Capron M., Ryffel B., Faveeuw C., Leite de Moraes M., et al. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 2007, 27:597-609.
9. Darmoise A., Teneberg S., Bouzonville L., Brady R.O., Beck M., Kaufmann S.H., Winau F. Lysosomal alpha-galactosidase controls the generation of self lipid antigens for natural killer T cells. Immunity 2010, 33:216-228.
10. Fujio M., Wu D., Garcia-Navarro R., Ho D.D., Tsuji M., Wong C.H. Structure-based discovery of glycolipids for CD1d-mediated NKT cell activation: tuning the adjuvant versus immunosuppression activity. J Am Chem Soc 2006, 128:9022-9023.
11. Yu K.O., Im J.S., Molano A., Dutronc Y., Illarionov P.A., Forestier C., Fujiwara N., Arias I., Miyake S., Yamamura T., et al. Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides. Proc Natl Acad Sci USA 2005, 102:3383-3388.
12. Goff R.D., Gao Y., Mattner J., Zhou D., Yin N., Cantu C., Teyton L., Bendelac A., Savage P.B. Effects of lipid chain lengths in alpha-galactosylceramides on cytokine release by natural killer T cells. J Am Chem Soc 2004, 126:13602-13603.
13. Schmieg J., Yang G., Franck R.W., Tsuji M. Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide. J Exp Med 2003, 198:1631-1641.
14. Miyamoto K., Miyake S., Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 2001, 413:531-534.
15. Li X., Fujio M., Imamura M., Wu D., Vasan S., Wong C.H., Ho D.D., Tsuji M. Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant. Proc Natl Acad Sci USA 2010, 107:13010-13015.
16. Im J.S., Arora P., Bricard G., Molano A., Venkataswamy M.M., Baine I., Jerud E.S., Goldberg M.F., Baena A., Yu K.O., et al. Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation. Immunity 2009, 30:888-898.
17. Godfrey D.I., Pellicci D.G., Patel O., Kjer-Nielsen L., McCluskey J., Rossjohn J. Antigen recognition by CD1d-restricted NKT T cell receptors. Semin Immunol 2010, 22:61-67.
18. Tilloy F., Treiner E., Park S.H., Garcia C., Lemonnier F., de la Salle H., Bendelac A., Bonneville M., Lantz O. An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammals. J Exp Med 1999, 189:1907-1921.
19. Treiner E., Duban L., Bahram S., Radosavljevic M., Wanner V., Tilloy F., Affaticati P., Gilfillan S., Lantz O. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 2003, 422:164-169.
20. Martin E., Treiner E., Duban L., Guerri L., Laude H., Toly C., Premel V., Devys A., Moura I.C., Tilloy F., et al. Stepwise development of MAIT cells in mouse and human. PLoS Biol 2009, 7:e54.
21. Huang S., Martin E., Kim S., Yu L., Soudais C., Fremont D.H., Lantz O., Hansen T.H. MR1 antigen presentation to mucosal-associated invariant T cells was highly conserved in evolution. Proc Natl Acad Sci USA 2009, 106:8290-8295.
22. Riegert P., Wanner V., Bahram S. Genomics, isoforms, expression, and phylogeny of the MHC class I-related MR1 gene. J Immunol 1998, 161:4066-4077.
23. Okamoto N., Kanie O., Huang Y.Y., Fujii R., Watanabe H., Shimamura M. Synthetic alpha-mannosyl ceramide as a potent stimulant for an NKT cell repertoire bearing the invariant Valpha19-Jalpha26 TCR alpha chain. Chem Biol 2005, 12:677-683.
24. Shimamura M. Non-reducing end alpha-mannosylated glycolipids as potent activators for invariant Valpha19 TCR-bearing natural killer T cells. Carbohydr Res 2008, 343:2010-2017.
25. Huang S., Gilfillan S., Kim S., Thompson B., Wang X., Sant A.J., Fremont D.H., Lantz O., Hansen T.H. MR1 uses an endocytic pathway to activate mucosal-associated invariant T cells. J Exp Med 2008, 205:1201-1211.
26. Gold M.C., Cerri S., Smyk-Pearson S., Cansler M.E., Vogt T.M., Delepine J., Winata E., Swarbrick G.M., Chua W.J., Yu Y.Y., et al. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol 2010, 8:e1000407.
27. Le Bourhis L., Martin E., Peguillet I., Guihot A., Froux N., Core M., Levy E., Dusseaux M., Meyssonnier V., Premel V., et al. Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol 2010, 11:701-708.
28. Lo W.F., Ong H., Metcalf E.S., Soloski M.J. T cell responses to Gram-negative intracellular bacterial pathogens: a role for CD8+ T cells in immunity to Salmonella infection and the involvement of MHC class Ib molecules. J Immunol 1999, 162:5398-5406.
29. Milligan G.N., Flaherty L., Braciale V.L., Braciale T.J. Nonconventional (TL-encoded) major histocompatibility complex molecules present processed viral antigen to cytotoxic T lymphocytes. J Exp Med 1991, 174:133-138.
30. Kerksiek K.M., Busch D.H., Pilip I.M., Allen S.E., Pamer E.G. H2-M3-restricted T cells in bacterial infection: rapid primary but diminished memory responses. J Exp Med 1999, 190:195-204.
31. D'Orazio S.E., Halme D.G., Ploegh H.L., Starnbach M.N. Class Ia MHC-deficient BALB/c mice generate CD8+ T cell-mediated protective immunity against Listeria monocytogenes infection. J Immunol 2003, 171:291-298.
32. Seaman M.S., Wang C.R., Forman J. MHC class Ib-restricted CTL provide protection against primary and secondary Listeria monocytogenes infection. J Immunol 2000, 165:5192-5201.
33. Xu H., Chun T., Choi H.J., Wang B., Wang C.R. Impaired response to Listeria in H2-M3-deficient mice reveals a nonredundant role of MHC class Ib-specific T cells in host defense. J Exp Med 2006, 203:449-459.
34. Doi T., Yamada H., Yajima T., Wajjwalku W., Hara T., Yoshikai Y. H2-M3-restricted CD8+ T cells induced by peptide-pulsed dendritic cells confer protection against Mycobacterium tuberculosis. J Immunol 2007, 178:3806-3813.
35. Braaten D.C., McClellan J.S., Messaoudi I., Tibbetts S.A., McClellan K.B., Nikolich-Zugich J., Virgin H.W. Effective control of chronic gamma-herpesvirus infection by unconventional MHC Class Ia-independent CD8 T cells. PLoS Pathog 2006, 2:e37.
36. Swanson P.A., Hofstetter A.R., Wilson J.J., Lukacher A.E. Cutting edge: shift in antigen dependence by an antiviral MHC class Ib-restricted CD8 T cell response during persistent viral infection. J Immunol 2009, 182:5198-5202.
37. Swanson P.A., Pack C.D., Hadley A., Wang C.R., Stroynowski I., Jensen P.E., Lukacher A.E. An MHC class Ib-restricted CD8 T cell response confers antiviral immunity. J Exp Med 2008, 205:1647-1657.
38. Renukaradhya G.J., Khan M.A., Shaji D., Brutkiewicz R.R. Vesicular stomatitis virus matrix protein impairs CD1d-mediated antigen presentation through activation of the p38 MAPK pathway. J Virol 2008, 82:12535-12542.
39. Renukaradhya G.J., Webb T.J., Khan M.A., Lin Y.L., Du W., Gervay-Hague J., Brutkiewicz R.R. Virus-induced inhibition of CD1d1-mediated antigen presentation: reciprocal regulation by p38 and ERK. J Immunol 2005, 175:4301-4308.
40. Park B., Spooner E., Houser B.L., Strominger J.L., Ploegh H.L. The HCMV membrane glycoprotein US10 selectively targets HLA-G for degradation. J Exp Med 2010, 207:2033-2041.
41. DeCloux A., Woods A.S., Cotter R.J., Soloski M.J., Forman J. Dominance of a single peptide bound to the class I(B) molecule, Qa-1b. J Immunol 1997, 158:2183-2191.
42. Cotterill L.A., Stauss H.J., Millrain M.M., Pappin D.J., Rahman D., Canas B., Chandler P., Stackpoole A., Simpson E., Robinson P.J., et al. Qa-1 interaction and T cell recognition of the Qa-1 determinant modifier peptide. Eur J Immunol 1997, 27:2123-2132.
43. Vance R.E., Kraft J.R., Altman J.D., Jensen P.E., Raulet D.H. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J Exp Med 1998, 188:1841-1848.
44. Vance R.E., Jamieson A.M., Raulet D.H. Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells. J Exp Med 1999, 190:1801-1812.
45. Petrie E.J., Clements C.S., Lin J., Sullivan L.C., Johnson D., Huyton T., Heroux A., Hoare H.L., Beddoe T., Reid H.H., et al. CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence. J Exp Med 2008, 205:725-735.
46. Hoare H.L., Sullivan L.C., Clements C.S., Ely L.K., Beddoe T., Henderson K.N., Lin J., Reid H.H., Brooks A.G., Rossjohn J. Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors. J Mol Biol 2008, 377:1297-1303.
47. Bland F.A., Lemberg M.K., McMichael A.J., Martoglio B., Braud V.M. Requirement of the proteasome for the trimming of signal peptide-derived epitopes presented by the nonclassical major histocompatibility complex class I molecule HLA-E. J Biol Chem 2003, 278:33747-33752.
48. Braud V.M., Allan D.S., Wilson D., McMichael A.J. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr Biol 1998, 8:1-10.
49. Guma M., Angulo A., Vilches C., Gomez-Lozano N., Malats N., Lopez-Botet M. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004, 104:3664-3671.
50. Guma M., Budt M., Saez A., Brckalo T., Hengel H., Angulo A., Lopez-Botet M. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 2006, 107:3624-3631.
51. Moser J.M., Gibbs J., Jensen P.E., Lukacher A.E. CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses. Nat Immunol 2002, 3:189-195.
52. Zhou J., Matsuoka M., Cantor H., Homer R., Enelow R.I. Cutting edge: engagement of NKG2A on CD8+ effector T cells limits immunopathology in influenza pneumonia. J Immunol 2008, 180:25-29.
53. Suvas S., Azkur A.K., Rouse B.T. Qa-1b and CD94-NKG2a interaction regulate cytolytic activity of herpes simplex virus-specific memory CD8+ T cells in the latently infected trigeminal ganglia. J Immunol 2006, 176:1703-1711.
54. Divito S., Cherpes T.L., Hendricks R.L. A triple entente: virus, neurons, and CD8+ T cells maintain HSV-1 latency. Immunol Res 2006, 36:119-126.
55. Ota T., Takeda K., Akiba H., Hayakawa Y., Ogasawara K., Ikarashi Y., Miyake S., Wakasugi H., Yamamura T., Kronenberg M., et al. IFN-gamma-mediated negative feedback regulation of NKT-cell function by CD94/NKG2. Blood 2005, 106:184-192.
56. Oliveira C.C., van Veelen P.A., Querido B., de Ru A., Sluijter M., Laban S., Drijfhout J.W., van der Burg S.H., Offringa R., van Hall T. The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects. J Exp Med 2010, 207:207-221.
57. Heinzel A.S., Grotzke J.E., Lines R.A., Lewinsohn D.A., McNabb A.L., Streblow D.N., Braud V.M., Grieser H.J., Belisle J.T., Lewinsohn D.M. HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells. J Exp Med 2002, 196:1473-1481.
58. Pietra G., Romagnani C., Mazzarino P., Falco M., Millo E., Moretta A., Moretta L., Mingari M.C. HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes. Proc Natl Acad Sci USA 2003, 100:10896-10901.
59. Salerno-Goncalves R., Fernandez-Vina M., Lewinsohn D.M., Sztein M.B. Identification of a human HLA-E-restricted CD8+ T cell subset in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine. J Immunol 2004, 173:5852-5862.
60. Grotzke J.E., Harriff M.J., Siler A.C., Nolt D., Delepine J., Lewinsohn D.A., Lewinsohn D.M. The Mycobacterium tuberculosis phagosome is a HLA-I processing competent organelle. PLoS Pathog 2009, 5:e1000374.
61. Hoare H.L., Sullivan L.C., Pietra G., Clements C.S., Lee E.J., Ely L.K., Beddoe T., Falco M., Kjer-Nielsen L., Reid H.H., et al. Structural basis for a major histocompatibility complex class Ib-restricted T cell response. Nat Immunol 2006, 7:256-264.
62. Sullivan L.C., Clements C.S., Rossjohn J., Brooks A.G. The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity. Tissue Antigens 2008, 72:415-424.
63. Lu L., Kim H.J., Werneck M.B., Cantor H. Regulation of CD8+ regulatory T cells: Interruption of the NKG2A-Qa-1 interaction allows robust suppressive activity and resolution of autoimmune disease. Proc Natl Acad Sci USA 2008, 105:19420-19425.
64. Leavenworth J.W., Schellack C., Kim H.J., Lu L., Spee P., Cantor H. Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab′)2. Proc Natl Acad Sci USA 2010, 107:2562-2567.
65. Smith T.R., Tang X., Maricic I., Garcia Z., Fanchiang S., Kumar V. Dendritic cells use endocytic pathway for cross-priming class Ib MHC-restricted CD8alphaalpha+TCRalphabeta+ T cells with regulatory properties. J Immunol 2009, 182:6959-6968.
66. Chen W., Zhang L., Liang B., Saenger Y., Li J., Chess L., Jiang H. Perceiving the avidity of T cell activation can be translated into peripheral T cell regulation. Proc Natl Acad Sci USA 2007, 104:20472-20477.
67. Jiang H., Kashleva H., Xu L.X., Forman J., Flaherty L., Pernis B., Braunstein N.S., Chess L. T cell vaccination induces T cell receptor Vbeta-specific Qa-1-restricted regulatory CD8(+) T cells. Proc Natl Acad Sci USA 1998, 95:4533-4537.
68. Jiang H., Wu Y., Liang B., Zheng Z., Tang G., Kanellopoulos J., Soloski M., Winchester R., Goldstein I., Chess L. An affinity/avidity model of peripheral T cell regulation. J Clin Invest 2005, 115:302-312.
69. Wu Y., Zheng Z., Jiang Y., Chess L., Jiang H. The specificity of T cell regulation that enables self-nonself discrimination in the periphery. Proc Natl Acad Sci USA 2009, 106:534-539.
70. Michaelsson J., Teixeira de Matos C., Achour A., Lanier L.L., Karre K., Soderstrom K. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition. J Exp Med 2002, 196:1403-1414.